Cancer Treatment Centers of America

In 2004, The Beljanski Foundation tested short RNA-fragments (extracts provided by Natural Source International, Ltd.) in a clinical trial conducted with cancer patients undergoing chemotherapy at the Cancer Treatment Center of America®  (CTCA). These studies have confirmed the ability of those fragments to support a normal level of platelets.

Publication:
Dose escalation study of an antithrombacytopenic agent in patients with chemotherapy induced thrombocytopenia” by Robert D Levin, MaryAnn Daehler, James F Grutsch, John L Hall, Digant Gupta, Christopher G Lis. Levin, Online magazine Bio Med Central BMC Cancer10:565 – 2010

Posted in List of Partners.